Russia
We are no longer operating in Russia. In 2021, less than 1% of Group sales were to Russia.
We remain hopeful that a peaceful resolution to the conflict can be found.
Further reading
Launch of first report on biotechnology opportunities in the personal care market
27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by...
Appointment of Chair Designate
22 September 2023: We are pleased to announce the appointment of Danuta Gray as a Non-Executive Director and Chair Designate
Sustainability expert Aris Vrettos joins Croda
The new position will see the sustainability expert challenge Croda to stretch its already industry-leading sustainability ambitions and commitments and support Croda’s business sectors in further...
U.S. Government to support expansion of Croda lipid systems capability
Today we announce a joint investment with the U.S. government to expand our U.S manufacturing capacity for lipid systems used in novel therapeutic drugs, such as mRNA vaccines